PerpEquitiesTop analysts on stock perps · Analyst
Evan Seigerman (BMO Capital): analyst track record on stock perps
Evan Seigerman of BMO Capital on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.7★
Success59%
Excess return+10.3%
rank#677
Ratings496
ratings on stock perps525
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 290 | 695 |
| Stock | 53 | 54 |
| Buy / hold / sell | 197 / 81 / 12 | 496 / 172 / 27 |
| Upgrades / downgrades / initiations | 4 / 4 / 7 | 6 / 13 / 13 |
| Price targets hit / missed | 105 / 179 (37%) | 338 / 350 (49%) |
| Avg. return after a rating (TipRanks) | +7.6% | +10.5% |
| Best / worst call | +1,224.0% / -72.7% | +1,224.0% / -81.1% |
After buy calls: median 21-day move +1.3% · vs S&P 500 -0.6% · targets hit within a year 50% (n = 465)
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $BIIB Biogen Inc. | Hold · Maintained | – | – | Sep 9, 2026 |
| $BMY Bristol Myers Squibb | Hold · Maintained | $60.00 | -5.9% | Sep 9, 2026 |
| $AMGN Amgen Inc. | Hold · Downgraded | $450 | +17.7% | Sep 8, 2026 |
| $BNTX BioNTech SE | Hold · Downgraded | $105 | +8.9% | Sep 8, 2026 |
| $ABBV AbbVie Inc. | Buy · Maintained | $300 | +17.7% | Sep 3, 2026 |
| $LLY Eli Lilly and Company | Buy · Maintained | $1,400 | +24.7% | Aug 31, 2026 |
| $GILD Gilead Sciences, Inc. | Buy · Maintained | $174 | +20.2% | Aug 27, 2026 |
| $MRK Merck & Co., Inc. | Buy · Reiterated | $170 | +17.5% | Aug 20, 2026 |
| $ABCL AbCellera Biologics Inc. | Buy · Maintained | $15.00 | +43.4% | Aug 17, 2026 |
| $NVO Novo Nordisk A/S | Hold · Maintained | $47.00 | +6.8% | Aug 17, 2026 |
| $PFE Pfizer Inc. | Buy · Maintained | $30.00 | +8.5% | Aug 17, 2026 |
| $REGN Regeneron Pharmaceuticals, Inc. | Buy · Maintained | $800 | +0.8% | Aug 17, 2026 |
| $VRTX Vertex Pharmaceuticals | Buy · Maintained | $600 | +16.6% | Aug 17, 2026 |
Recent ratings
- Sep 9, 2026 $BMY: Maintained · Hold · $60.00 · article
- Sep 9, 2026 $BIIB: Maintained · Hold · article
- Sep 8, 2026 $BNTX: Downgraded · Hold · $105 · article
- Sep 8, 2026 $AMGN: Downgraded · Hold · $450 · article
- Sep 3, 2026 $ABBV: Maintained · Buy · $300 · article
- Aug 31, 2026 $LLY: Maintained · Buy · $1,400 · article
- Aug 28, 2026 $BNTX: Maintained · Buy · $128 · article
- Aug 27, 2026 $GILD: Maintained · Buy · $174 · article
- Aug 20, 2026 $MRK: Reiterated · Buy · $170 · article
- Aug 17, 2026 $MRK: Reiterated · Buy · $142 · article
- Aug 17, 2026 $VRTX: Maintained · Buy · $600 · article
- Aug 17, 2026 $ABCL: Maintained · Buy · $15.00 · article
- Aug 17, 2026 $NVO: Maintained · Hold · $47.00 · article
- Aug 17, 2026 $BMY: Maintained · Hold · $60.00 · article
- Aug 17, 2026 $REGN: Maintained · Buy · $800 · article
- Aug 17, 2026 $LLY: Reiterated · Buy · $1,400 · article
- Aug 17, 2026 $AMGN: Reiterated · Buy · $450 · article
- Aug 17, 2026 $PFE: Maintained · Buy · $30.00 · article
- Aug 17, 2026 $GILD: Reiterated · Buy · $174
- Aug 12, 2026 $NVO: Reiterated · Hold · $47.00 · article
Evan Seigerman4.7★ · 59% success · +10.3% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.